Ribociclib Plus Letrozole in Patients with Hormone Receptor-positive, HER2-negative Advanced Breast Cancer with No Prior Endocrine Therapy: Subgroup Safety Analysis from The Phase...

por Borstnar, Simona, Palacova, Marketa, Łacko, Aleksandra, Timcheva, Constanta, Gal-Yam, Einav Nili, Papazisis, Konstantinos, Beniak, Juraj, Kudela, Pavol, Rubovszky, Gábor
Publicado 2022

microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study

por Kunc, Michał, Popęda, Marta, Szałkowska, Anna, Niemira, Magdalena, Bieńkowski, Michał, Pęksa, Rafał, Łacko, Aleksandra, Radecka, Barbara S., Braun, Marcin, Pikiel, Joanna, Litwiniuk, Maria, Pogoda, Katarzyna, Iżycka-Świeszewska, Ewa, Krętowski, Adam, Żaczek, Anna J., Biernat, Wojciech, Senkus-Konefka, Elżbieta
Publicado 2020

Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the mona...

por Martin, Miguel, Hegg, Roberto, Kim, Sung-Bae, Schenker, Michael, Grecea, Daniela, Garcia-Saenz, Jose Angel, Papazisis, Konstantinos, Ouyang, QuChang, Lacko, Aleksandra, Oksuzoglu, Berna, Reeves, James, Okera, Meena, Testa, Laura, Shimizu, Chikako, Denduluri, Neelima, Adamchuk, Hryhoriy, Dakhil, Shaker, Wei, Ran, Forrester, Tammy, Fernandez, Maria Munoz, Zimmermann, Annamaria, Headley, Desiree, Johnston, Stephen R. D.
Publicado 2022